OMER Share Price

Open 22.39 Change Price %
High 23.01 1 Day -0.45 -2.00
Low 21.98 1 Week -1.42 -6.06
Close 22.03 1 Month 0.76 3.57
Volume 528038 1 Year 10.69 94.27
52 Week High 27.09
52 Week Low 7.20
OMER Important Levels
Resistance 2 22.98
Resistance 1 22.59
Pivot 22.34
Support 1 21.47
Support 2 21.08
NASDAQ USA Most Active Stocks
DCTH 0.15 -11.76%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
QQQ 141.23 -0.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.03 50.00%
LOCM 0.09 50.00%
FALC 0.25 38.89%
VRTA 4.50 38.46%
ESMC 0.13 30.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
STXS 0.68 25.93%
OTT 2.39 25.13%
ATRM 1.70 21.43%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
PTSX 0.05 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Omeros Corporation (NASDAQ: OMER)

OMER Technical Analysis 3
As on 18th Aug 2017 OMER Share Price closed @ 22.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 14.08 & Buy for SHORT-TERM with Stoploss of 21.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
OMER Target for August
1st Target up-side 23.46
2nd Target up-side 25.21
3rd Target up-side 26.97
1st Target down-side 18.46
2nd Target down-side 16.71
3rd Target down-side 14.95
OMER Other Details
Segment EQ
Market Capital 234317888.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.omeros.com
OMER Address
OMER
201 Elliott Avenue West
Seattle, WA 98119
United States
Phone: 206-676-5000
Fax: 206-676-5005
OMER Latest News
Interactive Technical Analysis Chart Omeros Corporation ( OMER NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Omeros Corporation
OMER Business Profile
Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system. The Company develops pharmaceutical and therapeutic approaches to the management of surgical pain and inflammation, vasospasm, smooth muscle spasm, vascular restenosis and implantable surgical devices. Omeros develops products that are delivered directly to the site of tissue injury, preemptively inhibiting inflammation, pain and other problems associated with medical and surgical procedures.